García-Buey L - Search Results

1

Liver metastasis from neuroendocrine carcinoma after the use of the new direct-action antivirals against hepatitis C virus in a patient with past history of hepatocellular carcinoma.

Caldas M, Del Campo L, Freih-Fraih A, García-Buey L. Caldas M, et al. Rev Esp Enferm Dig. 2017 Apr;109(4):308-312. doi: 10.17235/reed.2017.4772/2016. Rev Esp Enferm Dig. 2017. PMID: 28287817 Free article.

2

[Tissue expression of antigenic recognition and intercellular adhesion molecules in chronic viral hepatitis].

García Monzón C, García Buey L, García Sánchez A, de Castro Marinas M, Muñoz Gómez R, Pajares JM, González Mateos F, Moreno Otero R. García Monzón C, et al. Rev Esp Enferm Dig. 1993 Nov;84(5):301-9. Rev Esp Enferm Dig. 1993. PMID: 7508239 Spanish.

3

[New antiviral agents in chronic viral hepatitis].

Gómez Cedenilla A, Zapater Hernández P, García Buey L, Abad Santos F, García Monzón C, González Mateos F, Moreno Otero R. Gómez Cedenilla A, et al. Rev Clin Esp. 1998 Feb;198(2):104-13. Rev Clin Esp. 1998. PMID: 9558926 Review. Spanish. No abstract available.

4

[Changes in iron metabolism in chronic hepatitis C].

Fernández Salazar L, García Buey L, Moreno Otero R. Fernández Salazar L, et al. Rev Esp Enferm Dig. 1999 Aug;91(8):583-9. Rev Esp Enferm Dig. 1999. PMID: 10491490 Review. Spanish.

5

Therapeutic advantages of pegylation of interferon alpha in chronic hepatitis C.

Medina J, García Buey L, Moreno Monteagudo JA, Trapero Marugán M, Moreno Otero R. Medina J, et al. Rev Esp Enferm Dig. 2003 Aug;95(8):568-74, 561-7. Rev Esp Enferm Dig. 2003. PMID: 14510631 Review. English, Spanish.

6

Hepatocellular carcinoma risk in patients with porphyria cutanea tarda.

Gisbert JP, García-Buey L, Alonso A, Rubio S, Hernández A, Pajares JM, García-Díez A, Moreno-Otero R. Gisbert JP, et al. Eur J Gastroenterol Hepatol. 2004 Jul;16(7):689-92. doi: 10.1097/01.meg.0000108318.52416.c9. Eur J Gastroenterol Hepatol. 2004. PMID: 15201583

7

[Diagnostic importance of scintigraphy in MEN type I hepatic tumors].

Rubio S, Legido J, Domínguez L, Del Campo L, Martín E, García Buey L. Rubio S, et al. Gastroenterol Hepatol. 2004 Jun-Jul;27(6):389-91. doi: 10.1016/s0210-5705(03)70483-x. Gastroenterol Hepatol. 2004. PMID: 15207142 Spanish. No abstract available.

8

Maintenance of T1 response as induced during PEG-IFNalpha plus ribavirin therapy controls viral replication in genotype-1 patients with chronic hepatitis C.

Trapero M, García-Buey L, Muñoz C, Vitón M, Moreno-Monteagudo JA, Borque MJ, Quintana NE, Moreno-Otero R. Trapero M, et al. Rev Esp Enferm Dig. 2005 Jul;97(7):481-90. doi: 10.4321/s1130-01082005000700003. Rev Esp Enferm Dig. 2005. PMID: 16262527 Free article. English, Spanish.

9

Association between angiogenesis soluble factors and disease progression markers in chronic hepatitis C patients.

Salcedo Mora X, Sanz-Cameno P, Medina J, Martín-Vílchez S, García-Buey L, Borque MJ, Moreno-Otero R. Salcedo Mora X, et al. Rev Esp Enferm Dig. 2005 Oct;97(10):699-706. doi: 10.4321/s1130-01082005001000003. Rev Esp Enferm Dig. 2005. PMID: 16351462 Free article. English, Spanish.

10

[Autoimmune hepatitis].

García-Buey L, Moreno-Otero R. García-Buey L, et al. Rev Esp Enferm Dig. 2006 Aug;98(8):624. doi: 10.4321/s1130-01082006000800009. Rev Esp Enferm Dig. 2006. PMID: 17099957 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page